Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
09/11/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
09/06/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
09/05/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
09/05/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
09/05/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
09/05/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
09/05/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
09/04/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
09/04/20244:01PMGlobeNewswire Inc.IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid LeukemiaNASDAQ:INABIN8bio Inc
08/29/20246:05AMGlobeNewswire Inc.IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:INABIN8bio Inc
08/12/20245:11PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INABIN8bio Inc
08/12/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
08/12/20248:05AMGlobeNewswire Inc.IN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of INB-100NASDAQ:INABIN8bio Inc
08/08/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
08/08/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
08/08/20244:05PMGlobeNewswire Inc.IN8bio Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INABIN8bio Inc
06/24/20248:00AMGlobeNewswire Inc.IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual ConferenceNASDAQ:INABIN8bio Inc
06/14/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/14/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/14/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/14/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/13/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
06/13/20244:01PMGlobeNewswire Inc.IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100NASDAQ:INABIN8bio Inc
06/03/20248:53AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
06/03/20246:05AMGlobeNewswire Inc.IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:INABIN8bio Inc
05/24/20248:00AMGlobeNewswire Inc.IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024NASDAQ:INABIN8bio Inc
05/23/20245:00PMGlobeNewswire Inc.IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual MeetingNASDAQ:INABIN8bio Inc
05/14/202410:00AMGlobeNewswire Inc.IN8bio Announces Upcoming Presentation at 2024 European Hematology Association CongressNASDAQ:INABIN8bio Inc
05/13/20248:00AMGlobeNewswire Inc.IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024NASDAQ:INABIN8bio Inc
05/09/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Your Recent History

Delayed Upgrade Clock